Neurology Central

Human-isolated monoclonal antibody shows promise for protective Zika treatment

Researchers at Vanderbilt University (MO, USA) and Washington University School of Medicine (MO, USA) have isolated a monoclonal antibody, known as ZIK-117, which has exhibited a demonstrable effect on reducing infection of the Zika virus in mouse models. The findings were published recently in Nature.
To view restricted content, please:

Leave A Comment